Galolo, Jane B.
HRN: 22-28-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2022
CEFTRIAXONE 1G (VIAL)
12/01/2022
12/08/2022
IVT
930 Mg
24 Hrs
AGE W/ Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes